Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-011082
Filing Date
2025-04-21
Accepted
2025-04-21 16:17:40
Documents
1
Period of Report
2025-04-21

Document Format Files

Seq Description Document Type Size
1 form4-04212025_080436.html 4  
1 form4-04212025_080436.xml 4 15485
  Complete submission text file 0001415889-25-011082.txt   16893
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Issuer) CIK: 0001117480 (see all company filings)

EIN.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
Vakiener Victoria (Reporting) CIK: 0001826263 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35867 | Film No.: 25853394